BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
1471 results:

  • 1. Transcranial Direct Current Stimulation for Anxiety During Laparoscopic colorectal cancer Surgery: A Randomized Clinical Trial.
    Li C; Tao M; Chen D; Wei Q; Xiong X; Zhao W; Tan W; Yang J; Han Y; Zhang H; Zhang S; Liu H; Cao JL
    JAMA Netw Open; 2024 Apr; 7(4):e246589. PubMed ID: 38635271
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Effect of probiotics and synbiotics on complications of wound infection after colorectal surgery: A meta-analysis.
    Jiang J; Ren F
    Int Wound J; 2024 Apr; 21(4):e14838. PubMed ID: 38577937
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
    Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
    Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinicopathological outcomes of microsatellite instability in colorectal cancer.
    Gülşen T; Ergenç M; Şenol Z; Emirzeoğlu L; Güleç B
    J Cancer Res Ther; 2024 Jan; 20(1):103-111. PubMed ID: 38554306
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Dynamic ctDNA-based analysis of drug-resistant gene alterations at RAS/BRAF wild-type metastatic colorectal cancer patients after cetuximab plus chemotherapy as the first-line treatment.
    Zhou YW; Zhao X; Ni L; Cao P; Leng WB; Zhu Q; Gou HF; Zhang J; Li XF; Qiu M
    Int Immunopharmacol; 2024 Apr; 131():111887. PubMed ID: 38503018
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comprehensive evaluation of serum hepatic proteins in predicting prognosis among cancer patients with cachexia: an observational cohort study.
    Huang JX; Zhang X; Tang M; Zhang Q; Deng L; Song CH; Li W; Shi HP; Cong MH
    BMC Cancer; 2024 Mar; 24(1):293. PubMed ID: 38438901
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetic specificity study using next-generation sequencing (NGS) of peritoneal metastatic colorectal cancer compared to primary colorectal cancer.
    Lee S; Shin W; Park DG; Namgung H
    Genes Genomics; 2024 Mar; 46(3):289-302. PubMed ID: 38316717
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
    Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
    Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Effectiveness of bevacizumab in the treatment of metastatic colorectal cancer: a systematic review and meta-analysis.
    Song Y; Mao Q; Zhou M; Liu CJ; Kong L; Hu T
    BMC Gastroenterol; 2024 Feb; 24(1):58. PubMed ID: 38302922
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
    Frei AL; McGuigan A; Sinha RRAK; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson T; Saunders MP; Oien KA; Maka N; Pezzella F; Campo L; Browne M; Glaire M; Kildal W; Danielsen HE; Hay J; Edwards J; Sansom O; Kelly C; Tomlinson I; Kerr R; Kerr D; Domingo E; ; Church DN; Koelzer VH
    Lancet Oncol; 2024 Feb; 25(2):198-211. PubMed ID: 38301689
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pks-positive Escherichia coli in tumor tissue and surrounding normal mucosal tissue of colorectal cancer patients.
    Miyasaka T; Yamada T; Uehara K; Sonoda H; Matsuda A; Shinji S; Ohta R; Kuriyama S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kanaka S; Ohashi R; Yoshida H
    Cancer Sci; 2024 Apr; 115(4):1184-1195. PubMed ID: 38297479
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Bidirectional Mendelian randomization analysis investigating the genetic association between primary breast cancer and colorectal cancer.
    Liu Y; Si M; Qian Y; Liu Y; Wang Z; Zhang T; Wang Z; Ye K; Xiang C; Xu L; Zhang Y; Xiao Z
    Front Immunol; 2023; 14():1260941. PubMed ID: 38283349
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Can neoadjuvant chemoradiotherapy before lateral pelvic lymph node dissection improve local control and prognosis in rectal cancer patients with clinically suspected lateral lymph node metastasis? A multicenter lateral node study in China.
    Xie Z; Chen Q; Feng B; Jiang Y; Wang X; Xing W; Liu Q;
    BMC Cancer; 2024 Jan; 24(1):115. PubMed ID: 38263067
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.
    Chiba Y; Kagabu M; Osakabe M; Ito R; Sato S; Takatori E; Kaido Y; Nagasawa T; Shoji T; Yanagawa N; Baba T
    Jpn J Clin Oncol; 2024 Apr; 54(4):424-433. PubMed ID: 38251744
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Occurrence and Risk Factors for Acute Urinary Retention and Urinary Tract Infection in Patients Undergoing Urinary Drainage after colorectal Resection.
    Song Z; Yu L; Wu Q; Zhang Y
    Arch Esp Urol; 2023 Dec; 76(10):772-779. PubMed ID: 38186070
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of prognostic nutritional index change on prognosis after colorectal cancer surgery under propofol or sevoflurane anesthesia.
    Zhang L; Liu C; Yan Q; Cai X
    BMC Anesthesiol; 2024 Jan; 24(1):12. PubMed ID: 38172695
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Inflammatory bowel diseases: Transformation of representations. A review].
    Maev IV; Bakulin IG; Skalinskaya MI; Skazyvaeva EV
    Ter Arkh; 2023 Dec; 95(12):1064-1074. PubMed ID: 38158940
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Is Precision Surgery Applicable to colorectal Liver Metastases? A Systematic Review and Meta-analysis of Studies that Investigate the Association of Surgical Technique with Outcomes in the Context of Distinct Tumor Biology.
    Pikoulis E; Papaconstantinou D; Pikouli A; Pararas N; Buettner S; Wang J; Stasinos G; Belias M; Dellaportas D; Pozios I; Antoniou E; Beyer K; Kreis ME; Pawlik TM; Margonis GA
    Ann Surg Oncol; 2024 Mar; 31(3):1823-1832. PubMed ID: 38155339
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cellular Ligand-Receptor Perturbations Unravel MEIS2 as a Key Factor for the Aggressive Progression and prognosis in Stage II/III colorectal cancer.
    Xu H; Chen S; Li J; Weng S; Ren Y; Zhang Y; Wang L; Liu L; Guo C; Xing Z; Luo P; Cheng Q; Han X; Liu Z
    J Proteome Res; 2024 Feb; 23(2):760-774. PubMed ID: 38153233
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in
    Tsai HL; Huang CW; Chen YC; Su WC; Chang TK; Chen PJ; Li CC; Chang YT; Wang JY
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138211
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 74.